Merck & Co., Inc.

BRSE:010683053 Stock Report

Market Cap: CHF 222.0b

Merck Balance Sheet Health

Financial Health criteria checks 4/6

Merck has a total shareholder equity of $44.6B and total debt of $38.1B, which brings its debt-to-equity ratio to 85.6%. Its total assets and total liabilities are $117.5B and $73.0B respectively. Merck's EBIT is $18.9B making its interest coverage ratio 20.7. It has cash and short-term investments of $14.6B.

Key information

85.6%

Debt to equity ratio

US$38.13b

Debt

Interest coverage ratio20.7x
CashUS$14.59b
EquityUS$44.56b
Total liabilitiesUS$72.97b
Total assetsUS$117.53b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 010683053's short term assets ($40.4B) exceed its short term liabilities ($29.6B).

Long Term Liabilities: 010683053's short term assets ($40.4B) do not cover its long term liabilities ($43.4B).


Debt to Equity History and Analysis

Debt Level: 010683053's net debt to equity ratio (52.8%) is considered high.

Reducing Debt: 010683053's debt to equity ratio has reduced from 96.9% to 85.6% over the past 5 years.

Debt Coverage: 010683053's debt is well covered by operating cash flow (47.9%).

Interest Coverage: 010683053's interest payments on its debt are well covered by EBIT (20.7x coverage).


Balance Sheet


Discover healthy companies